Amaç: Açık radikal retropubik prostatektomi hakkındaki güncel literatürün derlenmesi ve üniversite kliniğimizde yapılan son 250 açık radikal retropubik prostatektomi vakalarının sonuçlarının bildirilmesi. Materyal ve Metot: Radikal prostatektomi, açık retropubik, prostat kanseri, komplikasyonlar ve komorbidite anahtar kelimeleri seçildi ve Pubmed veritabanı kullanılarak literatür taraması yapıldı. Marmara Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalında yapılan son 250 açık radikal retropubik prostatektomi vakasının dosyaları tarandı. Bulgular: Hastaların % 69, 2sinde tümör prostat bezi ile sınırlı kalırken, % 30.8inde pozitif cerrahi sınır, kapsül invazyonu, seminal vezikül invazyonu ya da bunların kombinasyonu saptandı. Sinir koruyucu radikal retropubik prostatektomi hastalarının ameliyat sonrası dönemde idrar kontinansını ve erektil işlevi geri kazanmalarının daha başarılı olduğu saptandı. Radikal retropubik prostatektomi sonrası vakaların % 12, 4ünde ortalama 53,8 aylık takip ve ortalama 20,7 ay progresyon süresi ile kanser progresyonu saptandı. Sonuç: Radikal prostatektominin üç hedefi olan; kanser kontrolü, idrar kontrolünün korunması ve cinsel işlevin korunması hedeflerine, açık radikal retropubik prostatektominin uzun dönem tecrübesi ile ulaşılmıştır.
Objective: To review the current literature of open radical retropubic prostatectomy and report the results of the last 250 open radical retropubic prostatectomies performed in our University clinic. Patients and Methods: A literature review was performed using the PubMed database with combinations of the following keywords radical prostatectomy, open retropubic, prostate cancer, complications and comorbidity. Charts of the most recent 250 consecutive patients who had undergone radical retropubic prostatectomy at the Urology Department of Marmara University School of Medicine were reviewed. Results: In 69.2% of the cases the tumor was confined within the prostate gland, whereas 30.8% of the cases had tumors with either positive surgical margins, capsular penetration, invasion of seminal vesicles or a combination of these features. Nerve-sparing radical retropubic prostatectomy patients were found to be more successful in achieving continence and erectile function in the post operative period. Cancer progressions were experienced in 12.4% of the cases following radical retropubic prostatectomy at a mean follow-up of 53.8 months with a mean time to progression of 20.7 months. Conclusion: The three goals of radical prostatectomy; cancer control, preservation of urinary control and preservation of sexual function were achieved with the long-time experience of open radical prostatectomy.
___
1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 Mar;58(2):71-96. doi: 10.3322/CA.2007.0010
2. Boyle P, Ferlay J. Cancer incidence and mortality in Europe 2004. Ann Oncol 2005 Mar;16(3):481-488. doi10.1093/annonc/mdi098
3. Young H. Radical perineal prostatectomy. Johns Hopkins Hosp Bull 1905;16:315-21.
4. Memmelaar J, Millin T. Total prostatovesiculectomy; retropubic approach. J Urol 1949 Sep;62(3): 340-348.
5. Walsh PC, Donker PJ. Impotence following radical prostatectomy: Insight into etiology and prevention. J Urol 1982; 128: 492497. doi:10.1016/S0022-5347(02)80325-1
6. Walsh PC, Partin AW. Anatomic Radical Retropubic Prostatectomy. In: Wein, Kavoussi, Novick, Partin, Peters, eds. Campbell-Walsh Urology. 9th edition. Philadelphia: Saunders Elsevier, 2007: Chapter 97.
7. Heidenreich A., Bolla M., Joniau S. et al. EAU Guidelines on Prostate Cancer 2010. http://www.uroweb.org/guidelines/onlin guidelines/doi:10.1016/j.eururo.2010.10.039
8. Roehl KA, Han M, Ramos CG, et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results. J Urol 2004; 172: 910914. DOI: 10.1097/01.ju.0000134888.22332.bb
9. Kundu SD, Roehl KA, Eggener SE, et al. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004; 172: 22272231. DOI:
10.1097/01.ju.0000145222.94455.73 10. Han M, Partin AW, Pound CR, et al. Long-term biochemical diseasefree and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28: 555 565. DOI: 10.1016/S0094- 0143%2805%2970163-4
11. Türkeri LN, Temiz Y, Yazici CM, Tinay I. A new suture technique for anastomosis in radical retropubic prostatectomy and early removal of urethral catheter. Can J Urol 2007; 14 (6): 3734- 3738.
12. Donovan JL, Peters TJ, Abrams P, et al. Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol 2000; 164(6): 1948-1955. doi:10.1016/S0022- 5347(05)66926-1
13. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5- item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11(6): 319- 326.
14. Holmberg L, Bill-Axelson A, Helgesen F, et al. Scandinavian Prostatic Cancer Group Study Number 4. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002: 12; 347(11): 781-789.
15. Abraham NE, Makarov DV, Laze J, et al. Patient centered outcomes in prostate cancer treatment: predictors of satisfaction up to 2 years after open radical retropubic prostatectomy. J Urol 2010; 184(5): 1977-1981. doi:10.1016/j.juro.2010.06.099
16. Pound CR, Partin AW, Eisenberger MA, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 15911597. doi:10.1001/jama.281.17.1591
17. Hull GW, Rabbani F, Abbas F, et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002; 167: 528 534. doi:10.1016/S0022-5347(01)69079-7